Package 0121-0956-08

Brand: atovaquone

Generic: atovaquone
NDC Package

Package Facts

Identity

Package NDC 0121-0956-08
Digits Only 0121095608
Product NDC 0121-0956
Product ID 0121-0956_3dd9fcd8-8f05-43cb-a095-756f191f703d
Description

1 BOTTLE in 1 CARTON (0121-0956-08) / 210 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2025-04-04
Brand atovaquone
Generic atovaquone
Sample Package No

Linked Drug Pages (1)

Atovaquone ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3dd9fcd8-8f05-43cb-a095-756f191f703d", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["df6086d3-6100-422a-bf23-e9610027749b"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0121-0956-08)  / 210 mL in 1 BOTTLE", "package_ndc": "0121-0956-08", "marketing_start_date": "20250404"}], "brand_name": "Atovaquone", "product_id": "0121-0956_3dd9fcd8-8f05-43cb-a095-756f191f703d", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "0121-0956", "generic_name": "Atovaquone", "labeler_name": "PAI Holdings, LLC dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA214272", "marketing_category": "ANDA", "marketing_start_date": "20250404", "listing_expiration_date": "20261231"}